167 related articles for article (PubMed ID: 29611025)
1. Expressions of some antioxidant genes in SH-SY5Y cells treated with β-lapachone, morphine and electromagnetic field.
Mahmoudinasab H; Saadat M
Mol Biol Rep; 2018 Jun; 45(3):379-387. PubMed ID: 29611025
[TBL] [Abstract][Full Text] [Related]
2. Electromagnetic Field Could Protect SH-SY5Y Cells Against Cisplatin Cytotoxicity, But Not MCF-7 Cells.
Mahmoudinasab H; Saadat M
DNA Cell Biol; 2018 Apr; 37(4):330-335. PubMed ID: 29446648
[TBL] [Abstract][Full Text] [Related]
3. Effects of electromagnetic field, cisplatin and morphine on cytotoxicity and expression levels of DNA repair genes.
Sanie-Jahromi F; Saadat M
Mol Biol Rep; 2018 Oct; 45(5):807-814. PubMed ID: 29968116
[TBL] [Abstract][Full Text] [Related]
4. Short-term Exposure to 50-Hz Electromagnetic Field and Alterations in
Mahmoudinasab H; Saadat M
Open Access Maced J Med Sci; 2016 Dec; 4(4):548-550. PubMed ID: 28028389
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of antioxidant genes in human SH-SY5Y cells after treatment with morphine.
Saify K; Saadat I; Saadat M
Life Sci; 2016 Jan; 144():26-9. PubMed ID: 26596265
[TBL] [Abstract][Full Text] [Related]
6. β-Lapachone increases phase II antioxidant enzyme expression via NQO1-AMPK/PI3K-Nrf2/ARE signaling in rat primary astrocytes.
Park JS; Lee YY; Kim J; Seo H; Kim HS
Free Radic Biol Med; 2016 Aug; 97():168-178. PubMed ID: 27242267
[TBL] [Abstract][Full Text] [Related]
7. Effects of extremely low frequency electromagnetic field and cisplatin on mRNA levels of some DNA repair genes.
Sanie-Jahromi F; Saadat I; Saadat M
Life Sci; 2016 Dec; 166():41-45. PubMed ID: 27721000
[TBL] [Abstract][Full Text] [Related]
8. NQO1-Mediated Tumor-Selective Lethality and Radiosensitization for Head and Neck Cancer.
Li LS; Reddy S; Lin ZH; Liu S; Park H; Chun SG; Bornmann WG; Thibodeaux J; Yan J; Chakrabarti G; Xie XJ; Sumer BD; Boothman DA; Yordy JS
Mol Cancer Ther; 2016 Jul; 15(7):1757-67. PubMed ID: 27196777
[TBL] [Abstract][Full Text] [Related]
9. Cisplatin enhances the anticancer effect of beta-lapachone by upregulating NQO1.
Terai K; Dong GZ; Oh ET; Park MT; Gu Y; Song CW; Park HJ
Anticancer Drugs; 2009 Nov; 20(10):901-9. PubMed ID: 19738461
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of NAD(P)H:quinone oxidoreductase by radiation potentiates the effect of bioreductive beta-lapachone on cancer cells.
Choi EK; Terai K; Ji IM; Kook YH; Park KH; Oh ET; Griffin RJ; Lim BU; Kim JS; Lee DS; Boothman DA; Loren M; Song CW; Park HJ
Neoplasia; 2007 Aug; 9(8):634-42. PubMed ID: 17786182
[TBL] [Abstract][Full Text] [Related]
11. β-lapachone significantly increases the effect of ionizing radiation to cause mitochondrial apoptosis via JNK activation in cancer cells.
Park MT; Song MJ; Lee H; Oh ET; Choi BH; Jeong SY; Choi EK; Park HJ
PLoS One; 2011; 6(10):e25976. PubMed ID: 21998736
[TBL] [Abstract][Full Text] [Related]
12. Heat shock increases expression of NAD(P)H:quinone oxidoreductase (NQO1), mediator of beta-lapachone cytotoxicity, by increasing NQO1 gene activity and via Hsp70-mediated stabilisation of NQO1 protein.
Dong GZ; Youn H; Park MT; Oh ET; Park KH; Song CW; Choi EK; Park HJ
Int J Hyperthermia; 2009; 25(6):477-87. PubMed ID: 19657853
[TBL] [Abstract][Full Text] [Related]
13. Beta-lapachone suppresses radiation-induced activation of nuclear factor-kappaB.
Dong GZ; Oh ET; Lee H; Park MT; Song CW; Park HJ
Exp Mol Med; 2010 May; 42(5):327-34. PubMed ID: 20200474
[TBL] [Abstract][Full Text] [Related]
14. Tumor-selective, futile redox cycle-induced bystander effects elicited by NQO1 bioactivatable radiosensitizing drugs in triple-negative breast cancers.
Cao L; Li LS; Spruell C; Xiao L; Chakrabarti G; Bey EA; Reinicke KE; Srougi MC; Moore Z; Dong Y; Vo P; Kabbani W; Yang CR; Wang X; Fattah F; Morales JC; Motea EA; Bornmann WG; Yordy JS; Boothman DA
Antioxid Redox Signal; 2014 Jul; 21(2):237-50. PubMed ID: 24512128
[TBL] [Abstract][Full Text] [Related]
15. β-lapachone regulates mammalian inositol pyrophosphate levels in an NQO1- and oxygen-dependent manner.
Eisenbeis VB; Qiu D; Gorka O; Strotmann L; Liu G; Prucker I; Su XB; Wilson MSC; Ritter K; Loenarz C; Groß O; Saiardi A; Jessen HJ
Proc Natl Acad Sci U S A; 2023 Aug; 120(34):e2306868120. PubMed ID: 37579180
[TBL] [Abstract][Full Text] [Related]
16. beta-Lapachone-induced apoptosis in human prostate cancer cells: involvement of NQO1/xip3.
Planchon SM; Pink JJ; Tagliarino C; Bornmann WG; Varnes ME; Boothman DA
Exp Cell Res; 2001 Jul; 267(1):95-106. PubMed ID: 11412042
[TBL] [Abstract][Full Text] [Related]
17. Modulating endogenous NQO1 levels identifies key regulatory mechanisms of action of β-lapachone for pancreatic cancer therapy.
Li LS; Bey EA; Dong Y; Meng J; Patra B; Yan J; Xie XJ; Brekken RA; Barnett CC; Bornmann WG; Gao J; Boothman DA
Clin Cancer Res; 2011 Jan; 17(2):275-85. PubMed ID: 21224367
[TBL] [Abstract][Full Text] [Related]
18. Susceptibility of cancer cells to beta-lapachone is enhanced by ionizing radiation.
Park HJ; Ahn KJ; Ahn SD; Choi E; Lee SW; Williams B; Kim EJ; Griffin R; Bey EA; Bornmann WG; Gao J; Park HJ; Boothman DA; Song CW
Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):212-9. PubMed ID: 15629614
[TBL] [Abstract][Full Text] [Related]
19. eIF2 kinases mediate β-lapachone toxicity in yeast and human cancer cells.
Menacho-Márquez M; Rodríguez-Hernández CJ; Villaronga MÁ; Pérez-Valle J; Gadea J; Belandia B; Murguía JR
Cell Cycle; 2015; 14(4):630-40. PubMed ID: 25590579
[TBL] [Abstract][Full Text] [Related]
20. Albumin binding revitalizes NQO1 bioactivatable drugs as novel therapeutics for pancreatic cancer.
Dou L; Liu H; Wang K; Liu J; Liu L; Ye J; Wang R; Deng H; Qian F
J Control Release; 2022 Sep; 349():876-889. PubMed ID: 35907592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
